SC

Santhosh Chinthala

Active Director Director DIN 10981176
DIN 10981176 First appointment Mar 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Santhosh Chinthala

Data last updated:

Santhosh Chinthala is a Director at Allocin Pharmaceuticals Private Limited (since 2025). The company operates in Paper.

DIN 10981176
Primary Designation Director
Industry Paper
First Appointment 03 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Mar 20252025Active

Board colleagues of Santhosh Chinthala

NameDINCompanyDesignation
Bixam Maloth10965759Allocin Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Allocin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Santhosh Chinthala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santhosh Chinthala

Santhosh Chinthala currently holds 1 directorship: Allocin Pharmaceuticals Private Limited (Director, since 03 Mar 2025).

Santhosh Chinthala was first appointed on 03 Mar 2025 as Director at Allocin Pharmaceuticals Private Limited.

The current boards of Santhosh Chinthala's companies include Bixam Maloth (Allocin Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available